Celebi et al., 1993 - Google Patents

THE EFFECT OF BETA-CYCLODEXTRIN AND PENETRATION ADDITIVES ON THE RELEASE OF NAPROXEN FROM OINTMENT BASES

Celebi et al., 1993

Document ID: 9860315117376996469
Author: Celebi N; Kislal O; Tarimci N
Publication year: 1993
Publication venue: Pharmazie

External Links

Cited by

Snippet

The in vitro release of naproxen (1) from various ointment bases; including gel base, University of California Hospital base (UCH) and water-washable emulsion base were studied. The effect of beta-cyclodextrin (beta-CD) and penetration additives (propylene …

Continue reading at avesis.gazi.edu.tr (other versions)

229920000858 Cyclodextrin 0 title abstract description 5

Similar Documents

Publication	Publication Date	Title
EP0248548A3 (en)	1988-03-30	Controlled release pharmaceutical composition
AR003908A1 (en)	1998-09-30	CONTROLLED RELEASE TABLET
DE69834025D1 (en)	2006-05-18	PHARMACEUTICAL PREPARATIONS AND METHOD FOR THE LOCAL ADMINISTRATION
CA2027592A1 (en)	1990-09-02	Solid pharmaceutical preparations of active form of vitamin d_ of improved stability
PT942724E (en)	2003-12-31	FORMULATIONS IN GEL FOR LIBERATION TOPIC OF PHARMACIES
ZA972394B (en)	1997-09-25	Devices and methods for percutaneous surgery.
EP0373499A3 (en)	1991-03-27	Antiperspirant and deodorant
DE69132407D1 (en)	2000-10-12	AEROSOL MEDICAL FORMULATIONS
BR0208158A (en)	2004-03-02	Sharing administration and communication of information over a computer network
ES2187201T3 (en)	2003-05-16	USE OF STEROLES AND STEROLESTERS TO NANOESCALA.
DK0948965T3 (en)	2004-07-05	Stable medical preparations containing 4,5-epoxymorphinane derivatives
CA2326198A1 (en)	1999-10-14	Cosolvent formulations
Celebi et al.	1993	THE EFFECT OF BETA-CYCLODEXTRIN AND PENETRATION ADDITIVES ON THE RELEASE OF NAPROXEN FROM OINTMENT BASES
YU19399A (en)	2001-09-28	Local anesthetic for external use
AU1761901A (en)	2001-06-06	System and method for skin lesion examination using multi-spectral, multi-sourcetransillumination
BR9807729A (en)	2000-02-15	Nimesulide gel systems for topical use
EE03663B1 (en)	2002-04-15	Method of preventing breast cancer, pharmaceutical preparation and product, and use of the active ingredient
EP0255937A3 (en)	1988-05-04	Skin-treatment products
AU6924698A (en)	1998-11-11	Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product
MY110074A (en)	1997-12-31	Pharmacuetical formulation.
EP2308918A3 (en)	2013-10-02	Organic, open cell foam materials
WO2001077214A3 (en)	2002-04-04	Organic, low density microcellular materials
ATE60231T1 (en)	1991-02-15	INSOLUBLE DRUG DELIVERED LOCALLY IN THE EAR.
ZA925130B (en)	1993-05-05	Pharmaceutical formulation.
Celebi et al.	1994	Studies on direct compression of spironolactone tablets using cyclodextrin polymer